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P U B L I S H E D B Y E L S E V I E R I N C .iMAILL E T T E R S T O T H E E D I T O R typical chest pain (15% vs. 9%, p ¼ 0.002). On the other hand,
Gender Difference in the
Prognostic Value of CTA?
The prognostic value of coronary computed tomographic angi-
ography (CTA) is emerging, and especially detected obstructive
coronary artery disease (CAD) is a strong independent predictor
for events (1). Meanwhile, the pathophysiology of acute coronary
syndromes in men and women differs. In contrast to events in
men, coronary events in women occur more often in the absence
of obstructive CAD (2) and are frequently based on plaque
erosion (3,4). The goal of this studywas to investigate the ability
of coronary CTA to predict coronary events, in both men
and women with stable chest pain.
We prospectively investigated 1,210 stable chest pain pa-
tients who underwent coronary CTA between January 1, 2007
and June 1, 2010. The institution’s ethics committee approved
the study. Using the American Heart Association’s 16-segment
model, CAD was reported for every segment as no CAD (no
lesion), nonobstructive CAD (lesion with diameter stenosis
<50%), or obstructive CAD (lesion with diameter stenosis
$50%). Patients were subsequently categorized as having no
CAD, any CAD ($1 nonobstructive and/or obstructive le-
sions), or obstructive CAD ($1 obstructive lesions).
The study group consisted of 640 men (53%) and 570
women (47%). Women, as compared with men, were signiﬁ-
cantly older (58  11 years vs. 56  11 years, p < 0.001), more
often had a positive family history (43% vs. 33%, p< 0.001) andFigure 1. Event-Free Survival for Men and Women With Different Grades
(A) Kaplan-Meier curves are shown for men and women with and without obs
women with and without any CAD.men, as compared with women, more often had any CAD (70%
vs. 56%, p < 0.001) as well as obstructive CAD (34% vs. 21%,
p < 0.001).
Patients were followed up for amean 1,166 269 days. A total
of 3 cardiac deaths, 12 myocardial infarctions, 7 unstable angina,
and 38 late revascularizations (>60 days after CTA) were re-
ported (n ¼ 60 coronary events; 38 occurred in men and 22 in
women, p ¼ 0.11). The presence of obstructive CAD predicted
signiﬁcantly the occurrence of the combined endpoint, both in
men and women. The annualized event rate for men with and
without obstructive CADwas 5.12% and 0.15% (p< 0.001). For
women with and without obstructive CAD, the annualized event
rate was 4.83% and 0.28% (p < 0.001). Moreover, for men and
women without any CAD, the annualized event rate was 0% and
0.39% (p¼ 0.26). There were no signiﬁcant interactions between
sex and obstructive or any CAD (p ¼ 0.54 and p ¼ 0.15). In
Figure 1, Kaplan-Meier curves were calculated to assess sex
differences in patients: 1) with and without obstructive CAD;
and 2) with and without any CAD. The presence of obstructive
CAD as well as any CAD clearly resulted in a worse outcome
for both men and women. In a Cox regression model, the hazard
ratio for obstructive CAD was 37.2 (95% conﬁdence interval
[CI]: 8.9 to 154.3; p < 0.001) in men and 18.4 (95% CI: 6.2 to
54.4; p < 0.001) in women. In an exploratory adjusted model,
controlling for traditional risk factors, the hazard ratio for
obstructive CAD remained predictive (p < 0.001) in women.
Also in men, the presence of obstructive CAD was an indepen-
dent predictor; hazard ratio ¼ 36.9 (95% CI: 8.9 to 153.3; p <
0.001). Sex was not predictive of outcome (p ¼ 0.71).of CAD
tructive coronary artery disease (CAD) ($50% stenosis) and (B) for men and
Figure 1. Distribution of LAVi in Healthy Subjects (N [ 285)
The short black arrow points to the mean indexed left atrial volume (LAVi) of
30.3 ml/m2, which is greater than the current published reference value of 22
ml/m2 for normal (long black arrow).
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530A limitation of this study is that coronary CTA was performed
within clinical workup, which could implicate referral bias. Possibly,
clinical information known to the reader might have inﬂuenced
coronary CTA assessment as well. The nonsigniﬁcant difference in
event rate between men and women with normal coronary CTA
might be due to differences in risk factors or referral patterns, which
this study did not have the power to detect.
In conclusion, obstructive CAD signiﬁcantly predicted events in
both men and women. Despite the small numbers and hypothesis-
generating nature of our study, these ﬁndings further validate the
role of coronary CTA to effectively risk stratify women and men.
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Left Atrial Volumes
Should We Reset the Reference Standard?
Left atrial (LA) volume has been shown to be a prognostic indicator
of cardiovascular (CV) events and a marker of diastolic dysfunction
(1,2). Normative values for indexed LA volume (LAVi) have been
established to be 22  6 ml/m2 (3). Yet, these values are on the basis
of small sample size studies, from a period with different imaging
technology and using inconsistent measurement techniques.
We aimed to re-examine the normal reference standards for
LAVi in a contemporary healthy population. We searched our
institutional database for a 1-year period to identify healthy subjects
with normal echocardiograms. Medical records were comprehen-
sively reviewed to select healthy patients (no CV risk factors,
pulmonary or renal disease). LA volume was calculated by thebiplane area–length method (3). Diastolic parameters were assessed.
Furthermore, a healthy validation subset of 20 subjects was exam-
ined prospectively.
From June 2009 to June 2010, 285 healthy subjects were
identiﬁed and LA volumes measured. The mean LAVi was 30.3 
6 ml/m2 (mean age 38.3  14.8 years, 61.4% women) with no
difference observed between men and women (30.3  7.0 ml/m2
vs. 30.5  6.0 ml/m2, p ¼ 0.81) and no age differences in absolute
or indexed LA volumes in the entire healthy cohort or by sex.
Mean diastolic parameters were normal. Thirty percent
of subjects had a LAVi $34 ml/m2da cutoff used to iden-
tify those with abnormal diastolic function (1). E/A, average
E0, and E/E0 were not signiﬁcantly different between this group
and those with a LAVi <34 ml/m2. The prospective cohort of
20 healthy subjects, matched to age (38.3  7.0 years), sex
(60% women), and body surface area (1.8  0.2 m2) had similar
mean LAVi to the retrospective cohort (31.7  6.0 ml/m2 vs. 30.3
 7.0 ml/m2; prospective vs. retrospective p ¼ 0.35).
Reassessment of LAVi in a contemporary healthy cohort suggests
that normative reference ranges of LAVi should be higher than
previously reported. In the present study, the mean LAVi in healthy
subjects was 30.3  6.5 ml/m2, 38% higher compared with current
reference values for mean normal LAVi (22  6 ml/m2) (3) (Fig. 1).
Various factors may account for the discrepancy be-
tween previously reported values and our results. Current
reference values are on the basis of relatively small sample size
studies and obtained from a period with different imaging tech-
nology. With improved spatial resolution in current imaging
systems, measurement of LA boundaries may be more accurate.
The conﬂuence of the pulmonary veins may also be better
